Genicular Artery Embolization (GAE) vs inTra-articular Corticosteroid Injection for Osteoarthriti… (NCT06929585) | Clinical Trial Compass
TerminatedNot Applicable
Genicular Artery Embolization (GAE) vs inTra-articular Corticosteroid Injection for Osteoarthritic Knee Pain.
Stopped: The trial was terminated due to infeasible enrollment. Only one participant was enrolled, and the comparator arm was not initiated.
Taiwan1 participantsStarted 2025-03-25
Plain-language summary
This study investigates genicular artery embolization (GAE) as a minimally invasive alternative to ntra-articular corticosteroid injections (IA) or treating knee osteoarthritis (OA) pain. Designed as a randomized controlled tria, the study compares pain relief effectiveness and safety between GAE and IA over a 12-month follow-up. Eligible participants are aged over 40 with symptomatic knee OA resistant to conservative treatment. Primary outcomes focus on pain reduction (NRS score), while secondary measures include function, quality of life, imaging findings, and adverse events.
Who can participate
Age range40 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
✓. Insufficient or resistant to conservative treatment, including oral analgesics, physical therapy, intra-articular injections for at least 3 months, before the enrollment.
✓. Weight bearing X ray of knee: osteoarthritis of Kellgren-Lawrence grade 1, 2, or 3.
Exclusion criteria
✕. History of trauma in recent 6 months.
✕. Bleeding tendency.
✕. Poor renal function (serum creatinine \> 2.0 mg/dL).
✕. Pregnancy or breast-feeding.
✕. Severe peripheral arterial occlusive disease (PAOD).
✕. Local infections or inflammatory arthritis of knee.